Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma

被引:17
作者
Bille, Andrea [1 ,2 ]
Okiror, Lawrence [1 ,2 ]
Skanjeti, Andrea [3 ]
Errico, Luca [4 ]
Arena, Vincenzo [3 ]
Penna, Daniele [3 ]
Ardissone, Francesco [4 ]
Pelosi, Ettore [3 ]
机构
[1] Guys & St Thomas Hosp NHS Fdn Trust, Dept Thorac Surg, London, England
[2] Kings Coll London, Div Canc Studies, London WC2R 2LS, England
[3] PET Ctr, IRMET, Turin, Italy
[4] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Unit Thorac Surg, Turin, Italy
关键词
PET/CT; Adenocarcinoma; Squamous cell carcinoma; Lymph node staging; Accuracy; IASLC LUNG-CANCER; FDG UPTAKE; STAGING PROJECT; PET/CT;
D O I
10.1093/ejcts/ezs366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study was to analyze the specificity and sensitivity of integrated positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology (adenocarcinoma vs squamous cell carcinoma), and to identify the factors related to false-negative findings. A retrospective, single-institution review of 353 consecutive patients with suspected or pathologically proven, potentially resectable non-small-cell lung cancer (NSCLC) who had integrated PET/CT scanning at the same centre. Lymph node staging was pathologically confirmed on tissue specimens obtained at mediastinoscopy and/or thoracotomy. Statistical evaluation of PET/CT results was performed on a per-patient and per-nodal-station basis. A total of 2286 nodal stations (1643 mediastinal, 333 hilar and 310 intrapulmonary) were evaluated. Adenocarcinoma was the final diagnosis in 244 patients and squamous carcinoma in 109 patients. Nodes were positive for malignancy in 80 (32.8%) of 244 patients with adenocarcinoma (N1 = 31; N2 = 48 and N3 = 1) and in 32 (29.3%) of 109 with squamous carcinoma (N1 = 21 and N2 = 11). PET/CT in the adenocarcinoma group had a sensitivity, specificity and accuracy of 53.8, 91.5 and 79.1%, and in the squamous cell group, of 87.5, 81.8 and 83.5%, respectively in a per-patient analysis. In the analysis for N2 disease on a per-patient basis, the sensitivity, specificity and accuracy were 38.8, 97.4, and 85.7% for the adenocarcinoma group and 81.8, 91.8 and 90.8% in the squamous cell group. In the adenocarcinoma group, the mean diameter of false-negative lymph nodes was 7 mm (standard deviation [SD] +/- 2.5 mm) compared with the diameter of true-positive lymph nodes of 12.5 (SD +/- 4 mm; P < 0.00001). In the squamous cell group, the mean diameter of false-negative lymph nodes was 7.4 mm (SD +/- 2.8 mm) compared with the diameter of true-positive lymph nodes of 14.7 (SD +/- 6 mm; P < 0.005). In the adenocarcinoma group, false-negative lymph nodes were statistically correlated with the presence of vascular invasion and in the squamous cell group only with the maximum standardized uptake value (SUVmax) < 5.4. The sensitivity of PET/CT in detecting nodal metastasis in patients with adenocarcinoma is too low to avoid any further invasive staging procedure. Ultrasound-guided needle biopsy or mediastinoscopy is still necessary in staging patients undergoing lung resection for adenocarcinoma.
引用
收藏
页码:574 / 579
页数:6
相关论文
共 19 条
[1]   Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography [J].
Bille, Andrea ;
Pelosi, Ettore ;
Skanjeti, Andrea ;
Arena, Vincenzo ;
Errico, Luca ;
Borasio, Piero ;
Mancini, Maurizio ;
Ardissone, Francesco .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) :440-445
[2]   Histological Subtypes of Lung Adenocarcinoma Have Differential 18F-Fluorodeoxyglucose Uptakes on the Positron Emission Tomography/Computed Tomography Scan [J].
Chiu, Chao-Hua ;
Yeh, Yi-Chen ;
Lin, Ko-Han ;
Wu, Yu-Chun ;
Lee, Yu-Chin ;
Chou, Teh-Ying ;
Tsai, Chun-Ming .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (10) :1697-1703
[3]   Biological correlates of FDG uptake in non-small cell lung cancer [J].
de Geus-Oei, Lioe-Fee ;
van Krieken, J. Han J. M. ;
Aliredjo, Riena P. ;
Krabbe, Paul F. M. ;
Frielink, Cathelijne ;
Verhagen, Ad F. T. ;
Boerman, Otto C. ;
Oyen, Wim J. G. .
LUNG CANCER, 2007, 55 (01) :79-87
[4]   ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer [J].
De Leyn, Paul ;
Lardinois, Didier ;
Van Schil, Paul E. ;
Rami-Porta, Ramon ;
Passlick, Bernward ;
Zielinski, Marcin ;
Walter, David A. ;
Lerut, Tony ;
Weder, Walter .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (01) :1-8
[5]   Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer - A meta-analysis [J].
Gould, MK ;
Kuschner, WG ;
Rydzak, CE ;
Maclean, CC ;
Demas, AN ;
Shigemitsu, H ;
Chan, JK ;
Owens, DK .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (11) :879-892
[6]   Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma [J].
Ketchedjian, Ara ;
Daly, Benedict D. T. ;
Fernando, Hiran C. ;
Florin, Lauren ;
Hunter, Curtis J. ;
Morelli, Donna M. ;
Shemin, Richard J. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (03) :544-548
[7]   Lymph Node Drainage Patterns and Micrometastasis in Lung Cancer [J].
Kim, Anthony W. .
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2009, 21 (04) :298-308
[8]   Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation [J].
Li, Minghuan ;
Sun, Yun ;
Liu, Yuhui ;
Han, Anqin ;
Zhao, Shuqiang ;
Ma, Li ;
Zheng, Jinsong ;
Yu, Jinming .
LUNG CANCER, 2010, 68 (03) :394-397
[9]   Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study [J].
Li, Xiaolin ;
Zhang, Huaqi ;
Xing, Ligang ;
Ma, Honglian ;
Xie, Peng ;
Zhang, Lin ;
Xu, Xiangying ;
Yue, Jinbo ;
Sun, Xindong ;
Hu, Xudong ;
Chen, Ming ;
Xu, Wengui ;
Chen, Lusheng ;
Yu, Jinming .
RADIOTHERAPY AND ONCOLOGY, 2012, 102 (02) :246-250
[10]   A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer [J].
Lu, Peiou ;
Yu, Lijuan ;
Li, Yingci ;
Sun, Yajuan .
NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (07) :646-651